Amicus Therapeutics
FOLD
$10.66
Share price
-0.19%
Change (1 day)
-10.19%
Change (1 year)
Categories
Operating Margin for Amicus Therapeutics (FOLD)
Operating Margin as of April 2024 (TTM): -55.07%
According to Amicus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -55.07%. At the end of 2022 the company had an Operating Margin of -62.24%.
Operating Margin history for Amicus Therapeutics from 2008 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -62.24% | -9.05% |
| 2021 | -68.44% | -29.1% |
| 2020 | -96.53% | -47.81% |
| 2019 | -184.94% | -48.34% |
| 2018 | -358.03% | -69.38% |
| 2017 | -1,169.46% | -70.77% |
| 2016 | -4,001.27% | |
| 2014 | -5,600.90% | -67.78% |
| 2013 | -17,382.64% | 6061.45% |
| 2012 | -282.12% | 26.26% |
| 2011 | -223.44% | -96.31% |
| 2010 | -6,053.69% | 61849.95% |
| 2009 | -9.77% | -96.67% |
| 2008 | -293.69% | -88.56% |
| 2007 | -2,567.54% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | 39.02% | -170.86% | 🇩🇰 Denmark |
 Biogen BIIB | 31.30% | -156.84% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -140.93% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | -87,620.60% | 159,007.68% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -343.04% | 522.92% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -108.77% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.